BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xia H, Chen J, Shi M, Gao H, Sekar K, Seshachalam VP, Ooi LLP, Hui KM. EDIL3 is a novel regulator of epithelial-mesenchymal transition controlling early recurrence of hepatocellular carcinoma. Journal of Hepatology 2015;63:863-73. [DOI: 10.1016/j.jhep.2015.05.005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhao S, Tang Y, Wang R, Najafi M. Mechanisms of cancer cell death induction by paclitaxel: an updated review. Apoptosis 2022. [PMID: 35849264 DOI: 10.1007/s10495-022-01750-z] [Reference Citation Analysis]
2 Liu Y, Li R, Wang X, Xue Z, Yang X, Tang B. Comprehensive Analyses of MELK-Associated ceRNA Networks Reveal a Potential Biomarker for Predicting Poor Prognosis and Immunotherapy Efficacy in Hepatocellular Carcinoma. Front Cell Dev Biol 2022;10:824938. [DOI: 10.3389/fcell.2022.824938] [Reference Citation Analysis]
3 Xu H, Ma Z, Mo X, Chen X, Xu F, Wu F, Chen H, Zhou G, Xia H, Zhang C. Inducing Synergistic DNA Damage by TRIP13 and PARP1 Inhibitors Provides a Potential Treatment for Hepatocellular Carcinoma. J Cancer 2022;13:2226-37. [PMID: 35517402 DOI: 10.7150/jca.66020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lin Z, Jiang C, Lv D, Lin D. Identification of EDIL3 biomarkers as a biomarker and potential therapeutic target of canine mammary carcinomas based on integrated bioinformatics analysis. Veterinary Immunology and Immunopathology 2022;249:110432. [DOI: 10.1016/j.vetimm.2022.110432] [Reference Citation Analysis]
5 Jia X, Chen B, Li Z, Huang S, Chen S, Zhou R, Feng W, Zhu H, Zhu X. Identification of a Four-Gene-Based SERM Signature for Prognostic and Drug Sensitivity Prediction in Gastric Cancer. Front Oncol 2021;11:799223. [PMID: 35096599 DOI: 10.3389/fonc.2021.799223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wu MZ, Yuan YC, Huang BY, Chen JX, Li BK, Fang JH, Zhuang SM. Identification of a TGF-β/SMAD/lnc-UTGF positive feedback loop and its role in hepatoma metastasis. Signal Transduct Target Ther 2021;6:395. [PMID: 34785655 DOI: 10.1038/s41392-021-00781-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Zhang Y, Liu Z, Li X, Liu L, Wang L, Han X, Li Z. Comprehensive Molecular Analyses of a Six-Gene Signature for Predicting Late Recurrence of Hepatocellular Carcinoma. Front Oncol 2021;11:732447. [PMID: 34568069 DOI: 10.3389/fonc.2021.732447] [Reference Citation Analysis]
8 Shi X, Tu S, Zhu L. Risk characteristics with seven epithelial-mesenchymal transition-related genes are used to predict the prognosis of patients with hepatocellular carcinoma. J Gastrointest Oncol 2021;12:1884-94. [PMID: 34532136 DOI: 10.21037/jgo-21-394] [Reference Citation Analysis]
9 Li M, Zhong D, Li G. Regulatory role of local tissue signal Del-1 in cancer and inflammation: a review. Cell Mol Biol Lett 2021;26:31. [PMID: 34217213 DOI: 10.1186/s11658-021-00274-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Ashrafizadeh M, Mirzaei S, Hashemi F, Zarrabi A, Zabolian A, Saleki H, Sharifzadeh SO, Soleymani L, Daneshi S, Hushmandi K, Khan H, Kumar AP, Aref AR, Samarghandian S. New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities. Biomed Pharmacother 2021;141:111824. [PMID: 34175815 DOI: 10.1016/j.biopha.2021.111824] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Chakravarthi S, Karikalan B. Molecular Biomarkers for Lung Adenocarcinoma: A Short Review. CCTR 2021;17:97-106. [DOI: 10.2174/1573394716666200724164654] [Reference Citation Analysis]
12 Boye A. A cytokine in turmoil: Transforming growth factor beta in cancer. Biomed Pharmacother 2021;139:111657. [PMID: 34243626 DOI: 10.1016/j.biopha.2021.111657] [Reference Citation Analysis]
13 Chung JW, Kim HT, Ha YS, Lee EH, Chun SY, Lee CH, Byeon KH, Choi SH, Lee JN, Kim BS, Kim TH, Yoo ES, Yoon GS, Baek MC, Kwon TG. Identification of a novel non-invasive biological marker to overcome the shortcomings of PSA in diagnosis and risk stratification for prostate cancer: Initial prospective study of developmental endothelial locus-1 protein. PLoS One 2021;16:e0250254. [PMID: 33901217 DOI: 10.1371/journal.pone.0250254] [Reference Citation Analysis]
14 Yan P, Huang Z, Mou T, Luo Y, Liu Y, Zhou B, Cao Z, Wu Z. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence. BMC Cancer 2021;21:436. [PMID: 33879119 DOI: 10.1186/s12885-021-08173-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Liang L, Zhu K, Tao J, Lu S. ORN: Inferring patient-specific dysregulation status of pathway modules in cancer with OR-gate Network. PLoS Comput Biol 2021;17:e1008792. [PMID: 33819263 DOI: 10.1371/journal.pcbi.1008792] [Reference Citation Analysis]
16 Huo Q, Ma Y, Yin Y, Qin G. Biomarker Identification for Liver Hepatocellular Carcinoma and Cholangiocarcinoma Based on Gene Regulatory Network Analysis. CBIO 2021;16:31-43. [DOI: 10.2174/1574893615666200317115609] [Reference Citation Analysis]
17 Giwa A, Fatai A, Gamieldien J, Christoffels A, Bendou H. Identification of novel prognostic markers of survival time in high-risk neuroblastoma using gene expression profiles. Oncotarget 2020;11:4293-305. [PMID: 33245713 DOI: 10.18632/oncotarget.27808] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Hyun YM, Seo SU, Choi WS, Kwon HJ, Kim DY, Jeong S, Kang GY, Yi E, Kim M, Ryu HJ, Looney MR, Choi EY, Kim HS. Endogenous DEL-1 restrains melanoma lung metastasis by limiting myeloid cell-associated lung inflammation. Sci Adv 2020;6:eabc4882. [PMID: 33158867 DOI: 10.1126/sciadv.abc4882] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
19 Luo L, Zhou Y, Zhang C, Huang J, Du J, Liao J, Bergholt NL, Bünger C, Xu F, Lin L, Tong G, Zhou G, Luo Y. Feeder-free generation and transcriptome characterization of functional mesenchymal stromal cells from human pluripotent stem cells. Stem Cell Research 2020;48:101990. [DOI: 10.1016/j.scr.2020.101990] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Gasca J, Flores ML, Jiménez-Guerrero R, Sáez ME, Barragán I, Ruíz-Borrego M, Tortolero M, Romero F, Sáez C, Japón MA. EDIL3 promotes epithelial-mesenchymal transition and paclitaxel resistance through its interaction with integrin αVβ3 in cancer cells. Cell Death Discov 2020;6:86. [PMID: 33014430 DOI: 10.1038/s41420-020-00322-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
21 Heng L, Jia Z, Sun J, Zhao Y, Zhang K, Zhu Y, Lu S. Integrated Analysis of Competing Endogenous RNAs Network Reveals Potential Signatures in Osteosarcoma Development. Technol Cancer Res Treat 2020;19:1533033820957025. [PMID: 32912111 DOI: 10.1177/1533033820957025] [Reference Citation Analysis]
22 Seo ES, Lee EJ, Lee B, Shin M, Cho YS, Hyun JK, Cho HW, Ju HY, Yoo KH, Koo HH, Lee JW, Sung KW. Metastatic Burden Defines Clinically and Biologically Distinct Subgroups of Stage 4 High-Risk Neuroblastoma. J Clin Med 2020;9:E2730. [PMID: 32847064 DOI: 10.3390/jcm9092730] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Zhang P, Zhang H, Dong W, Wang Z, Qin Y, Wu C, Dong Q. IL-34 is a potential biomarker for the treatment of papillary thyroid cancer. J Clin Lab Anal 2020;34:e23335. [PMID: 32573824 DOI: 10.1002/jcla.23335] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Yu B, Liang H, Ye Q, Wang Y. Establishment of a Genomic-Clinicopathologic Nomogram for Predicting Early Recurrence of Hepatocellular Carcinoma After R0 Resection. J Gastrointest Surg 2021;25:112-24. [PMID: 32128678 DOI: 10.1007/s11605-020-04554-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Sun F, Wang J, Sun Q, Li F, Gao H, Xu L, Zhang J, Sun X, Tian Y, Zhao Q, Shen H, Zhang K, Liu J. Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma. J Exp Clin Cancer Res 2019;38:449. [PMID: 31684995 DOI: 10.1186/s13046-019-1455-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
26 Oplawski M, Dziobek K, Zmarzły N, Grabarek B, Tomala B, Leśniak E, Adwent I, Januszyk P, Dąbruś D, Boroń D. Evaluation of Changes in the Expression Pattern of EDIL3 in Different Grades of Endometrial Cancer. Curr Pharm Biotechnol 2019;20:483-8. [PMID: 30961491 DOI: 10.2174/1389201020666190408112822] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Tu S, Huang W, Huang C, Luo Z, Yan X. Contextual Regulation of TGF-β Signaling in Liver Cancer. Cells 2019;8:E1235. [PMID: 31614569 DOI: 10.3390/cells8101235] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
28 Chen D, Pan J, Chen Y, Xing W, Yan Y, Yuan Y, Zeng W. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target. British Journal of Anaesthesia 2019;122:e157-67. [DOI: 10.1016/j.bja.2018.09.030] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
29 Li J, Zhou P, Xu H, Tian S, Liu W, Zhao Y, Hu Z. Antitumor activity of integrin αVβ3 antibody conjugated-cationic microbubbles in liver cancer. Transl Cancer Res 2019;8:899-908. [PMID: 35116829 DOI: 10.21037/tcr.2019.05.29] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Feng YL, Chen DQ, Vaziri ND, Guo Y, Zhao YY. Small molecule inhibitors of epithelial-mesenchymal transition for the treatment of cancer and fibrosis. Med Res Rev 2020;40:54-78. [PMID: 31131921 DOI: 10.1002/med.21596] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 13.0] [Reference Citation Analysis]
31 Cai J, Tong Y, Huang L, Xia L, Guo H, Wu H, Kong X, Xia Q. Identification and validation of a potent multi-mRNA signature for the prediction of early relapse in hepatocellular carcinoma. Carcinogenesis 2019;40:840-52. [DOI: 10.1093/carcin/bgz018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
32 Qin Z, Chen Z, Weng J, Li S, Rong Z, Zhou C. Elevated HOXA13 expression promotes the proliferation and metastasis of gastric cancer partly via activating Erk1/2. Onco Targets Ther 2019;12:1803-13. [PMID: 30881033 DOI: 10.2147/OTT.S196986] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
33 Marasco G, Colecchia A, Colli A, Ravaioli F, Casazza G, Bacchi Reggiani ML, Cucchetti A, Cescon M, Festi D. Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection. Journal of Hepatology 2019;70:440-8. [DOI: 10.1016/j.jhep.2018.10.022] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 13.3] [Reference Citation Analysis]
34 Dai B, Zhang X, Shang R, Wang J, Yang X, Zhang H, Liu Q, Wang D, Wang L, Dou K. Blockade of ARHGAP11A reverses malignant progress via inactivating Rac1B in hepatocellular carcinoma. Cell Commun Signal 2018;16:99. [PMID: 30545369 DOI: 10.1186/s12964-018-0312-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
35 Cen WN, Pang JS, Huang JC, Hou JY, Bao WG, He RQ, Ma J, Peng ZG, Hu XH, Ma FC. The expression and biological information analysis of miR-375-3p in head and neck squamous cell carcinoma based on 1825 samples from GEO, TCGA, and peer-reviewed publications. Pathol Res Pract 2018;214:1835-47. [PMID: 30243807 DOI: 10.1016/j.prp.2018.09.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
36 Wu DC, Zhang MF, Su SG, Fang HY, Wang XH, He D, Xie YY, Liu XH. HEY2, a target of miR-137, indicates poor outcomes and promotes cell proliferation and migration in hepatocellular carcinoma. Oncotarget 2016;7:38052-63. [PMID: 27191260 DOI: 10.18632/oncotarget.9343] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
37 Zhang R, Wei YH, Zhao CY, Song HY, Shen N, Cui X, Gao X, Qi ZT, Zhong M, Shen W. EDIL3 depletion suppress epithelial-mesenchymal transition of lens epithelial cells via transforming growth factor β pathway. Int J Ophthalmol 2018;11:18-24. [PMID: 29375985 DOI: 10.18240/ijo.2018.01.04] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
38 Sun W, Zhang Z, Wang J, Shang R, Zhou L, Wang X, Duan J, Ruan B, Gao Y, Dai B, Qu S, Liu W, Ding R, Wang L, Wang D, Dou K. MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis. Oncotarget 2016;7:11595-608. [PMID: 26871477 DOI: 10.18632/oncotarget.7292] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
39 Xia H, Lee KW, Chen J, Kong SN, Sekar K, Deivasigamani A, Seshachalam VP, Goh BKP, Ooi LL, Hui KM. Simultaneous silencing of ACSL4 and induction of GADD45B in hepatocellular carcinoma cells amplifies the synergistic therapeutic effect of aspirin and sorafenib. Cell Death Discov 2017;3:17058. [PMID: 28900541 DOI: 10.1038/cddiscovery.2017.58] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
40 Jeong D, Ban S, Oh S, Jin Lee S, Yong Park S, Koh YW. Prognostic Significance of EDIL3 Expression and Correlation with Mesenchymal Phenotype and Microvessel Density in Lung Adenocarcinoma. Sci Rep 2017;7:8649. [PMID: 28819306 DOI: 10.1038/s41598-017-08851-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
41 Shen W, Zhu S, Qin H, Zhong M, Wu J, Zhang R, Song H. EDIL3 knockdown inhibits retinal angiogenesis through the induction of cell cycle arrest in vitro. Mol Med Rep 2017;16:4054-60. [PMID: 28765888 DOI: 10.3892/mmr.2017.7122] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
42 Chen P, Lei L, Wang J, Zou X, Zhang D, Deng L, Wu D. Downregulation of Talin1 promotes hepatocellular carcinoma progression through activation of the ERK1/2 pathway. Cancer Sci 2017;108:1157-68. [PMID: 28375585 DOI: 10.1111/cas.13247] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
43 Xia H, Kong SN, Chen J, Shi M, Sekar K, Seshachalam VP, Rajasekaran M, Goh BKP, Ooi LL, Hui KM. MELK is an oncogenic kinase essential for early hepatocellular carcinoma recurrence. Cancer Letters 2016;383:85-93. [DOI: 10.1016/j.canlet.2016.09.017] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 6.2] [Reference Citation Analysis]
44 Xia H, Li F, Hu X, Park W, Wang S, Jang Y, Du Y, Baik S, Cho S, Kang T, Kim DH, Ling D, Hui KM, Hyeon T. pH-Sensitive Pt Nanocluster Assembly Overcomes Cisplatin Resistance and Heterogeneous Stemness of Hepatocellular Carcinoma. ACS Cent Sci 2016;2:802-11. [PMID: 27924308 DOI: 10.1021/acscentsci.6b00197] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 12.8] [Reference Citation Analysis]
45 Layh-Schmitt G, Lu S, Navid F, Brooks SR, Lazowick E, Davis KM, Montagna C, Gadina M, Colbert RA. Generation and differentiation of induced pluripotent stem cells reveal ankylosing spondylitis risk gene expression in bone progenitors. Clin Rheumatol 2017;36:143-54. [PMID: 27864696 DOI: 10.1007/s10067-016-3469-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
46 Jiang SH, Wang Y, Yang JY, Li J, Feng MX, Wang YH, Yang XM, He P, Tian GA, Zhang XX, Li Q, Cao XY, Huo YM, Yang MW, Fu XL, Li J, Liu DJ, Dai M, Wen SY, Gu JR, Hong J, Hua R, Zhang ZG, Sun YW. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer. Oncotarget 2016;7:4226-40. [PMID: 26735172 DOI: 10.18632/oncotarget.6772] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
47 Giannelli G, Koudelkova P, Dituri F, Mikulits W. Role of epithelial to mesenchymal transition in hepatocellular carcinoma. J Hepatol. 2016;65:798-808. [PMID: 27212245 DOI: 10.1016/j.jhep.2016.05.007] [Cited by in Crossref: 209] [Cited by in F6Publishing: 227] [Article Influence: 34.8] [Reference Citation Analysis]
48 Marriott AS, Vasieva O, Fang Y, Copeland NA, McLennan AG, Jones NJ. NUDT2 Disruption Elevates Diadenosine Tetraphosphate (Ap4A) and Down-Regulates Immune Response and Cancer Promotion Genes. PLoS One. 2016;11:e0154674. [PMID: 27144453 DOI: 10.1371/journal.pone.0154674] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
49 Jiang G, Zhang L, Zhu Q, Bai D, Zhang C, Wang X. CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma. J Exp Clin Cancer Res. 2016;35:38. [PMID: 26928402 DOI: 10.1186/s13046-016-0313-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
50 Chang RM, Xu JF, Fang F, Yang H, Yang LY. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling. Tumour Biol 2016;37:10609-19. [PMID: 26861561 DOI: 10.1007/s13277-016-4919-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
51 Xiong J, Yang H, Luo W, Shan E, Liu J, Zhang F, Xi T, Yang J. The anti-metastatic effect of 8-MOP on hepatocellular carcinoma is potentiated by the down-regulation of bHLH transcription factor DEC1. Pharmacol Res 2016;105:121-33. [PMID: 26808085 DOI: 10.1016/j.phrs.2016.01.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
52 Lee S, Kim D, Jing F, Kim H, Yun C, Han D, Choi EY. Del-1 overexpression potentiates lung cancer cell proliferation and invasion. Biochemical and Biophysical Research Communications 2015;468:92-8. [DOI: 10.1016/j.bbrc.2015.10.159] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]